Q2 FY27 sales rise 36.6% as gross margin falls

Management guided margin improvementOrder pipeline disclosedInvestor Communications View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.9%Reaction day

₹3433.30

prior close

₹3335.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.3%+1.7% vs market

Commodity Chemicals peers, median of 58sector+0.0%+1.9% vs sector

On the reaction day the stock moved 1.7 pts more than Nifty Microcap 250 and 1.9 pts more than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.7

10m

+1.0

15m

+1.0

30m

+0.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.9+0.3+1.7+0.0+1.9

Next day

+1.4+2.4-1.1+0.4+0.9

-1.9+3.6-5.5+1.3-3.2

-0.2pendingpending+1.1-1.3

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Commodity Chemicals peers, median of 58Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Q2 FY27 revenue was ₹230.5 crore, up 36.6% year on year; H1 revenue was ₹417.7 crore, up 21.2%. H1 profit after tax was lower at ₹35.9 crore versus ₹36.5 crore. Gross margin fell to 32.5% from 39.1% and EBITDA margin to 13.3% from 16.2%. Management expects lower input prices and product scale-up to improve margins.

Likely market impact

Strong sales and signed orders support growth, but lower margins and new shares may reduce returns. HFC-32 commissioning is the next key event.